Loading: 100%
PAREXEL INTERNATIONAL CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 18,900 (as per Q3 2017)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker PRXLno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 175060708090
datesClosing price (adj.)
29.09.201788.08
27.09.201788.07
20.09.201788.06
13.09.201787.93
06.09.201787.81
30.08.201787.85
23.08.201787.66
16.08.201787.76
09.08.201787.67
02.08.201787.47
26.07.201787.44
19.07.201787.39
12.07.201787.34
05.07.201787.02
27.06.201787.01
20.06.201787.04
13.06.201782.61
06.06.201781.46
30.05.201779.71
23.05.201779.64
16.05.201779.35
09.05.201774.51
02.05.201765.37
25.04.201762.35
18.04.201761.17
11.04.201761.92
04.04.201761.95
28.03.201762.70
21.03.201761.25
14.03.201764.44
07.03.201764.83
28.02.201764.69
21.02.201765.80
14.02.201765.91
07.02.201762.63
31.01.201770.89
24.01.201769.62
17.01.201771.44
10.01.201768.50
03.01.201766.43
27.12.201665.58
19.12.201664.36
12.12.201665.39
05.12.201659.95
28.11.201658.34
21.11.201657.51
14.11.201656.55
07.11.201657.20
31.10.201658.26
24.10.201667.60
17.10.201666.33
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Sep 29, 2017, in USD
88.08n/a
Market Capitalisation
in million USD
4,466n/a
Enterprise Value
in million USD
4,718n/a
Common Shares Outstanding
as per Mar 31, 2017
50,700,000n/a
Preferred Shares Outstanding
as per Mar 31, 2017
n/a
Average Basic Shares Outstanding
TTM
52,050,000n/a
Average Diluted Shares Outstanding
TTM
52,775,000n/a
Index Membership
n/a
Business Summary
Parexel International Corp is a biopharmaceutical services company. It offers clinical research, clinical logistics, medical communications, and technology products and services to the pharmaceutical, biotechnology, and medical device industries.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 2,426n/a
Gross Profit 734n/a
Operating Income 252n/a
EBITDA 349n/a
Net Profit 155n/a
Balance Sheet
Cash and Cash Equivalents 249n/a
Receivables 506n/a
Total Current Assets 1,181n/a
PP&E 259n/a
Total Assets 4,072n/a
Accounts Payable 63n/a
Current Debt 17n/a
Total Current Liabilities 769n/a
Long-Term Debt 485n/a
Total Liabilities 1,403n/a
Total Equity 633n/a
Cash Flow
Depreciation & Amortisation 97n/a
Change in Working Capital -60n/a
Operating Cash Flow 261n/a
Net Change in PP&E and Intangibles -96n/a
Investing Cash Flow -163n/a
Dividends Paid 0n/a
Financing Cash Flow -46n/a
Total Change in Cash 41n/a
Free Cash Flow 133n/a
Profitability Ratios
Gross Margin 30.3%n/a
Operating Margin 10.4%n/a
Net Profit Margin 6.4%n/a
Return on Equity 24.5%n/a
Return on Assets 3.8%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 13.53n/a
EV/Sales 1.94n/a
Book to Market Value 0.14n/a
Other Ratios
Current Ratio 153.5%n/a
Liabilities to Equity Ratio 221.5%n/a
Debt to Assets Ratio 12.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
1,247
1,336
1,422
1,618
1,996
2,266
2,330
2,426
Sales & Services Revenue
1,247
1,336
1,422
1,618
1,996
2,266
2,330
2,426
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-887
-931
-1,008
-1,194
-1,469
-1,606
-1,659
-1,692
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
360
405
414
425
527
660
672
734
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-284
-305
-325
-330
-392
-461
-452
-482
Selling, General & Administrative
-216
-246
-259
-263
-319
-380
-367
-385
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
Depreciation & Amortization
-53
-60
-65
-66
-73
-81
-85
-97
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
-15
1
0
0
0
0
0
0
Operating Income (Loss)
76
100
90
95
135
199
220
252
Non-Operating Income (Loss)
-12
-20
-23
-9
-3
-12
0
-9
Interest Expense, net
-11
-10
-12
-7
-7
-9
-7
-9
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-1
-10
-11
-2
4
-3
7
0
Pretax Income (Loss), Adjusted
64
80
67
86
132
188
220
243
Abnormal Gains (Losses)
0
-17
-8
-6
1
0
-20
-28
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
-17
-8
-6
1
0
-20
-28
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
64
63
59
80
133
188
200
215
Income Tax (Expense) Benefit, net
-25
-22
-10
-17
-37
-59
-52
-60
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
39
42
49
63
96
129
148
155
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
39
42
49
63
96
129
148
155
Minority Interest
0
0
0
0
0
0
0
0
Net Income
39
42
49
63
96
129
148
155
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
39
42
49
63
96
129
148
155
Remarks
restated on Aug 26, 2011 n/a
calculated values,
restated on Aug 27, 2012 n/a
calculated values,
restated on Aug 22, 2013 n/a
calculated values,
restated on Aug 20, 2014 n/a
calculated values,
restated on Aug 25, 2015 n/a
calculated values,
restated on Sep 9, 2016 n/a
calculated values,
restated on Sep 9, 2016 n/a
calculated values,
restated on Sep 9, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
107
89
214
274
284
207
249
Cash & Cash Equivalents
n/a
95
89
214
144
188
207
249
Short Term Investments
n/a
12
0
0
130
96
0
0
Accounts & Notes Receivable
n/a
479
650
649
457
497
461
506
Accounts Receivable, Net
n/a
479
650
649
457
497
461
506
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
65
69
80
346
341
394
427
Prepaid Expenses
n/a
27
21
21
19
14
16
23
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
29
18
37
44
54
59
0
Income Taxes Receivable
n/a
0
6
0
4
0
13
25
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
9
23
22
278
274
307
378
Total Current Assets
n/a
651
808
943
1,077
1,122
1,062
1,181
Property, Plant & Equipment, Net
n/a
188
201
208
224
234
241
259
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
1,602
1,850
1,914
2,258
2,312
2,427
2,632
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
248
262
255
319
330
355
389
Other Intangible Assets
n/a
87
80
70
104
92
142
131
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
7
31
14
9
7
12
27
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1,260
1,476
1,574
1,826
1,884
1,918
2,085
Total Noncurrent Assets
n/a
1,790
2,051
2,121
2,482
2,546
2,668
2,891
Total Assets
n/a
2,441
2,859
3,064
3,559
3,668
3,730
4,072
Liabilities and owners' equity
Payables & Accruals
n/a
169 168553000
152 151904000
220 219575000
246 245733000
314 313741000
301 300600000
310 310200000
Accounts Payable
n/a
34 34353000
32 31724000
51 50783000
54 54232000
66 66483000
81 81200000
63 62600000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
134 134200000
120 120180000
169 168792000
192 191501000
247 247258000
219 219400000
248 247600000
Short Term Debt
n/a
32 32082000
6 5867000
5 5003000
20 20399000
13 12501000
9 8900000
17 16600000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
283 282980000
333 332509000
359 358796000
408 408096000
445 444990000
400 400000000
443 442600000
Deferred Revenue
n/a
247 247462000
312 311896000
331 331488000
379 378950000
422 422441000
372 371800000
420 420200000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
16 15977000
17 17216000
15 14998000
17 16512000
17 16592000
10 10000000
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
20 19541000
3 3397000
12 12310000
13 12634000
6 5957000
18 18200000
22 22400000
Total Current Liabilities
n/a
484 483615000
490 490280000
583 583374000
674 674228000
771 771232000
710 709500000
769 769400000
Long Term Debt
n/a
184 183707000
240 240102000
212 211784000
424 424074000
334 334443000
345 345400000
485 484800000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
114 113833000
133 133097000
127 127323000
142 142376000
151 150644000
145 144800000
149 148600000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
14 13618000
21 20766000
28 28226000
29 29386000
45 44523000
42 42200000
38 38300000
Deferred Tax Liabilities
n/a
32 32235000
31 30987000
25 24678000
35 35443000
33 32598000
33 33000000
19 19300000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
68 67980000
81 81344000
74 74419000
78 77547000
74 73523000
70 69600000
91 91000000
Total Noncurrent Liabilities
n/a
298 297540000
373 373199000
339 339107000
566 566450000
485 485087000
490 490200000
633 633400000
Total Liabilities
n/a
781 781155000
863 863479000
922 922481000
1,241 1240678000
1,256 1256319000
1,200 1199700000
1,403 1402800000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
234 234255000
252 251629000
280 280136000
114 114334000
1 547000
38 38300000
32 31900000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
247 246734000
296 295520000
359 358678000
455 454650000
575 575044000
723 722900000
738 737500000
Other Equity
n/a
-41 -41434000
19 18855000
-29 -29139000
-30 -30038000
2 2090000
-96 -95900000
-136 -136000000
Equity Before Minority Interest
n/a
440 439555000
566 566004000
610 609675000
539 538946000
578 577681000
665 665300000
633 633400000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
440 439555000
566 566004000
610 609675000
539 538946000
578 577681000
665 665300000
633 633400000
Total Liabilities & Equity
n/a
1,221 1220710000
1,429 1429483000
1,532 1532156000
1,780 1779624000
1,834 1834000000
1,865 1865000000
2,036 2036200000
Remarks restated on n/a restated on Aug 26, 2011 n/a restated on Aug 27, 2012 n/a restated on Aug 22, 2013 n/a restated on Aug 20, 2014 n/a restated on Aug 25, 2015 n/a restated on Sep 9, 2016 n/a restated on May 8, 2017 n/a
Cash Flow StatementCF data quality: 86% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
39
42
49
63
96
129
148
155
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
53
60
65
66
73
81
85
97
Non-Cash Items
48
43
18
11
8
5
-21
70
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-30
105
-134
94
7
72
-54
-60
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
110
250
-1
234
184
287
158
261
Change in Fixed Assets & Intangibles
-75
-79
-59
-74
-79
-73
-80
-96
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
-14
13
-2
-130
42
89
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-190
0
0
0
-97
0
-105
-67
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
1
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-265
-92
-46
-77
-305
-31
-96
-163
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
208
-59
30
-26
218
-88
7
147
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
5
7
8
12
-180
-148
13
-186
Increase in Capital Stock
5
7
8
12
15
7
13
14
Decrease in Capital Stock
0
0
0
0
-195
-155
0
-200
Other Financing Activities
-2
0
-2
5
15
12
7
-7
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
211
-52
37
-9
52
-224
26
-46
Net Cash Before Disc. Operations and FX
56
106
-11
149
-69
32
88
53
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
56
106
-11
149
-69
32
88
53
Effect of Foreign Exchange Rates
-12
-10
4
-25
0
12
-69
-12
Net Changes in Cash
44
96
-6
125
-70
44
19
41
Remarks
restated on Aug 26, 2011 n/a
calculated values,
restated on Aug 27, 2012 n/a
calculated values,
restated on Aug 22, 2013 n/a
calculated values,
restated on Aug 20, 2014 n/a
calculated values,
restated on Aug 25, 2015 n/a
calculated values,
restated on Sep 9, 2016 n/a
calculated values,
restated on Sep 9, 2016 n/a
calculated values,
restated on Sep 9, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo